MAP Pharmaceuticals, Inc.

• About Us 
  • Message from the CEO
  • Management Team
  • Board of Directors
  • Partnering
  • Contact Us
• Product Pipeline 
  • Migraine
  • Pediatric Asthma
  • Asthma/COPD
  • Diabetes
• Investor Relations 
  • IR Home
  • Press Releases
  • Events and Presentations
  • Corporate Governance
  • Management
  • Board of Directors
  • Committee Composition
  • Annual Reports
  • SEC Filings
  • Stock Information
  • Analyst Coverage
  • Contact Us
• Science & Technology 
• Publications 
  • Migraine
  • Asthma
  • Aerosol Science & Technology

Investor Relations

Print page     Email page

SEC Filings

View: All Filings Annual Quarterly Current Section 16 Proxy Other    Year: All Years 2010 2009 2008 2007

Filing	Description	Date Filed	Size
DEF 14A	definitive proxy statement	Apr 15, 2008	457.8 KB
4	wolff, henry ward	Mar 25, 2008	24.8 KB
3	wolff henry ward	Mar 25, 2008	20.8 KB
8-K	current report	Mar 25, 2008	32.5 KB
10-K	annual report	Mar 20, 2008	850.8 KB
SC 13G	statement of beneficial ownership	Mar 19, 2008	61.4 KB
8-K	current report	Feb 28, 2008	54.3 KB
SC 13G	statement of beneficial ownership	Feb 14, 2008	147.7 KB
SC 13G	statement of beneficial ownership	Feb 13, 2008	108.2 KB
SC 13G	statement of beneficial ownership	Feb 11, 2008	52.3 KB
8-K	current report	Feb 5, 2008	26.2 KB
8-K	current report	Jan 28, 2008	29.9 KB
4	shrewsbury, stephen b	Jan 24, 2008	24.8 KB
4	gianakakos, anastasios	Jan 24, 2008	19.8 KB
4	nelson, timothy s	Jan 24, 2008	24.7 KB
4	friedman, charlene a	Jan 24, 2008	24.8 KB
4	chai, christopher y	Jan 24, 2008	19.7 KB
4	armer, thomas a	Jan 24, 2008	24.7 KB
8-K	current report	Jan 16, 2008	41.5 KB
8-K	current report	Jan 7, 2008	39.8 KB
Showing 221-240 of 284 Page: 1 ... 10 11 12 13 14 15  Previous 20 | Next 20

= add filing to Briefcase

Stock Information

NASDAQ:MAPP $12.84	+ 0.04
Sep 10, 2010	12:07 PM ET

Quotes delayed at least 20 minutes.
Information provided by eSignal.